Karen L. Smith Acceleron Pharma Inc (XLRN) insider trading activity

XLRN Quotes by TradingView
Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held N/A

Karen L. Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Disposition due to a tender of shares in a change of control transaction
-
1,622 Reduced 100.0%
0 Common Stock
Apr 05 2021
SELL
Open market or private sale
$1,668,553 $140.64 p/Share
11,864 Reduced 87.97%
1,622 Common Stock
Apr 05 2021
BUY
Exercise of conversion of derivative security
$386,631 $43.32 p/Share
8,925 Added 39.82%
13,486 Common Stock
Apr 01 2021
SELL
Open market or private sale
$1,217,370 $136.4 p/Share
8,925 Reduced 66.18%
4,561 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$386,631 $43.32 p/Share
8,925 Added 39.82%
13,486 Common Stock
Jan 29 2021
BUY
Grant, award, or other acquisition
-
1,622 Added 26.23%
4,561 Common Stock

Also insider at

EBS
Emergent BioSolutions Inc. Healthcare
EVP, Chief Medical Officer
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
TALS
Talaris Therapeutics, Inc. Healthcare
Director
CRTX
Cortexyme, Inc. Healthcare
Chief Medical Officer
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
SKYE
Skye Bioscience, Inc. Healthcare
Director
CNTX
Context Therapeutics Inc. Healthcare
Director
KLS

Karen L. Smith

Director
Gaithersburg,, MD

Track Institutional and Insider Activities on XLRN

Follow ACCELERON PHARMA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLRN shares.

Notify only if

Insider Trading

Get notified when an Acceleron Pharma Inc insider buys or sells XLRN shares.

Notify only if

News

Receive news related to ACCELERON PHARMA INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XLRN